U.S. markets open in 4 hours 21 minutes
  • S&P Futures

    4,077.25
    -4.00 (-0.10%)
     
  • Dow Futures

    34,538.00
    -61.00 (-0.18%)
     
  • Nasdaq Futures

    12,015.00
    -27.25 (-0.23%)
     
  • Russell 2000 Futures

    1,889.70
    +2.20 (+0.12%)
     
  • Crude Oil

    80.37
    -0.18 (-0.22%)
     
  • Gold

    1,791.80
    +31.90 (+1.81%)
     
  • Silver

    22.27
    +0.49 (+2.27%)
     
  • EUR/USD

    1.0449
    +0.0041 (+0.40%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    20.95
    -0.94 (-4.29%)
     
  • GBP/USD

    1.2146
    +0.0084 (+0.69%)
     
  • USD/JPY

    136.3270
    -1.7530 (-1.27%)
     
  • BTC-USD

    17,109.35
    +230.64 (+1.37%)
     
  • CMC Crypto 200

    405.29
    +4.59 (+1.15%)
     
  • FTSE 100

    7,567.40
    -5.65 (-0.07%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

Amarin to Present at Two Upcoming Investor Conferences

Amarin Corporation plc
Amarin Corporation plc

DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, will present at two upcoming investor conferences:

H.C. Wainwright Global Investment Conference (May 23-26, 2022; Miami, Florida)

Date/Time: May 25, 2022, 12:00 p.m. ET/5:00 p.m. GMT+1
Webcast: https://journey.ct.events/view/7aff40b1-3f90-47dd-a827-a30d854fea27

Jefferies Healthcare Conference (June 8-10, 2022; New York, New York)

Date/Time: June 8, 2022, 1:00 p.m. ET/6:00 p.m. GMT+1
Webcast: https://wsw.com/webcast/jeff240/amrn/1843950

Both conference presentations will be webcast live and archived on the Company’s website in the Investor Relations section under Events and Presentation at Events | Amarin Corporation plc.

About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.

Availability of Other Information About Amarin
Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Amarin Contact Information
Investor Inquiries:
Investor Relations
Amarin Corporation plc
IR@amarincorp.com (investor inquiries)

Media Inquiries:
Communications
Amarin Corporation plc
PR@amarincorp.com (media inquiries)